Company intelligence / Profile preview

KangChen Bio-tech

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

KangChen Bio-tech provides advanced multi-omics analysis and technical services, including microarray, single-cell sequencing, next generation sequencing, and mass spectrometry platforms, primarily supporting non-coding RNA research; its technologies and services have contributed to over 2,500 peer-reviewed publications through its customers[6].

Modalities: Microarray-based technologyNext generation sequencingMass spectrometrySingle-cell sequencing
Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Aksomics (exclusive China partner and distributor for Arraystar Inc. products and services)[6]Arraystar (product technology/platform provider via Aksomics)[6]

Beyond the preview

Go deeper on KangChen Bio-tech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on KangChen Bio-tech.

Explore the full profile